Document:

Exhibit

Exhibit 4.4

NON-QUALIFIED STOCK OPTION AGREEMENT

THIS NON-QUALIFIED STOCK OPTION AGREEMENT (this “Agreement”) is made this 20th day of May 2019, by and between Travelzoo, a Delaware corporation ("Company") and Xiaobo (Scott) Wang ("Optionee"). 

WHEREAS, the Company and Optionee intend that Optionee will provide services to the Company effective May 20, 2019 or earlier, pursuant to an employment agreement dated February 2, 2019 (the “Employment Agreement”) and pursuant to a bonus plan that provides stock options on the condition that certain performance metrics are met as to the Asia Pacific segment (“Asia Pacific Bonus Plan”);

WHEREAS, in accordance with the Asia Pacific Bonus Plan, the Company desires to grant to Optionee the option to purchase certain shares of its stock, in accordance with the terms of this Agreement and the Asia Pacific Bonus Plan, with such option intended to be a nonstatutory stock option that is not an incentive stock option within the meaning of Section 422 of the Internal Revenue Code of 1986, as amended; and

NOW, THEREFORE, in consideration of the premises and of the mutual agreements hereinafter set forth, it is covenanted and agreed as follows:
1.     Grant and Terms of Option. Pursuant to action of the Compensation Committee of the Board of Directors of the Company (“Compensation Committee”), the Company grants, effective May 20, 2019 (“Date of Grant”) to Optionee the option to purchase all or any part of 100,000 shares of the common stock of the Company ("Common Stock") planned to vest over four (4) years as set forth in the table below, at the purchase price of $19.28 per share, which is the fair market value of the Common Stock determined as the NASDAQ official closing price on the Date of Grant; provided, however, that the right to exercise such option shall be, and is hereby, restricted as follows:
(a)    No shares may be purchased prior to May 20, 2019. Subject to the terms of this Agreement, the 100,000 stock options shall vest in installments provided that the following conditions are triggered:

1/5

	
		
	Vesting Date
	Percentage of Stock Options Vesting

	

Date of Grant
	

10%

	

Completion of Phase One Deliverables as set forth in the Asia Pacific Bonus Plan (“Performance Goal”), to be completed no later than three months following the Date of Grant (“Performance Measurement Date”) as determined in the sole discretion of Travelzoo 

	

15%

	

May 20, 2021, two years following Date of Grant
 
	

25%

	

May 20, 2022, three years following Date of Grant

	

25%

	

May 20, 2023, four years following Date of Grant
	

25%

On or after May 20, 2023, during the term hereof, provided that the Optionee satisfied the Performance Goal, Optionee will have become entitled to purchase the entire number of shares (100,000 shares) to which this option relates. The stock options subject to a performance goal may be exercised only to the extent they have become vested by the respective Performance Measurement Date, and any stock option shares subject to a performance goal that fail to meet the Performance Goal vesting trigger by the Performance Measurement Date shall be forfeited.
(b)    In no event may this option or any part thereof be exercised after the expiration of five (5) years from the Date of Grant, which shall be the term of the option.
(c)    The purchase price of the shares subject to the option may be paid for (i) in cash, (ii) in the discretion of the Board of Directors, by tender of shares of Common Stock already owned by Optionee, or (iii) in the discretion of the Board of Directors, by such other method as the Board of Directors may determine. 
(d)    The option may not be exercised for a fraction of a share. 
(e)    The option may not be exercised if Optionee is no longer employed by the Company subject to the provisions of section 4 of this Agreement.
(f)    The option may not be exercised if shareholder approval is not received and may not be exercised prior to the registration of the shares being offered under the Agreement, which registration shall be filed by the Company with the Securities and Exchange Commission no later than sixty (60) days following the Company’s 2019 annual shareholder meeting.   
2.    Anti-Dilution Provisions. In the event that, during the term of this Agreement, there is any change in the number of shares of outstanding Common Stock of the Company by reason of stock dividends, recapitalizations, mergers, consolidations, split-ups, combinations or exchanges of shares and the like, not including any issuances of shares for consideration or capital increases by the Company, the number of shares covered by this option agreement and the price thereof shall be adjusted, to the same proportionate number of shares and price as in this original agreement.

2/5

3.    Non-Transferability. Neither the option hereby granted nor any rights thereunder or under this Agreement may be assigned, transferred or in any manner encumbered except by will or the laws of descent and distribution, and any attempted assignment, transfer, mortgage, pledge or encumbrance except as herein authorized, shall be void and of no effect. The option may be exercised during Optionee's lifetime only by Optionee or his guardian or legal representative as set forth herein.
4.    Termination of Employment. In the event of the termination of the Employment Agreement prior to its expiration, or to the extent the Company terminates employment of Optionee, including upon death or disability, Optionee’s (or, in the event of death, the legatee or legatees of Optionee under his last will, or his personal representatives or distributees) right to exercise the option, only to the extent it was vested and he was entitled to exercise it on the date of termination of services or employment, shall continue for 90 days after such termination but not after five (5) years from the Date of Grant. If the Optionee (or, in the event of death, the legatee or legatees of Optionee under his last will, or his personal representatives or distributees) does not exercise the option within 90 days following such termination of Employment, any unexercised vested option shall be null and void.
5.    Method of Exercise/Shares Issued on Exercise of Option. The option may be exercised (in whole or in part) at any time during the period specified in this Agreement, by delivering to the Secretary of the Company not less than thirty (30) business days prior to the date of exercise (or such shorter period as the Company shall approve) (a) a written notice of exercise designating the number of shares to be purchased, signed by Optionee, and (b) payment of the full amount of the purchase price of the shares with respect to which the option is exercised. If the written notice of exercise is delivered by mail, or by any other means of delivery, the date of delivery and the date of exercise shall be the date the written notice is actually received by the Secretary. It is the intention of the Company that on any exercise of this option it will transfer to Optionee shares of its authorized but unissued stock or transfer Treasury shares or utilize any combination of Treasury shares and authorized but unissued shares, to satisfy its obligations to deliver shares on any exercise hereof. No rights of a shareholder shall exist with respect to the Common Stock under this option as a result of the mere grant of this option.
6.    Board Administration. The Company’s Board of Directors, or any successor or committee authorized by the Board of Directors, subject to the express terms of this option, shall have plenary authority to interpret any provision of this option and to make any determinations necessary or advisable for the administration of this option and the exercise of the rights herein granted, and may waive or amend any provisions hereof in any manner not adversely affecting the rights granted to Optionee by the express terms hereof.
7.    Option not an Incentive Stock Option. It is intended that this option shall not be treated as an incentive stock option under Section 422 of the Internal Revenue Code of 1986, as amended, or otherwise qualify for any special tax benefits to Optionee.
8.    No Contract of Employment. Nothing contained in this Agreement shall be considered or construed as creating a contract of employment for any specified period of time.
9.    Restrictions on Exercise. This option may not be exercised if the issuance of Common Stock upon Optionee’s exercise or the method of payment of consideration for such Common Stock would constitute a violation of any applicable Federal or state securities law or other applicable law or regulation. As a condition to the exercise of this option, the Company may require Optionee to make any representations and warranty to the Company as may be required by any applicable law or regulation.
10.    Termination of Option. Notwithstanding anything to the contrary herein, this option shall not be exercisable after the expiration of the term of five (5) years from the Date of Grant, as set forth in section 1(b) hereof.
11.    Withholding upon Exercise. The Company reserves the right to withhold, in accordance with any applicable laws, from any consideration payable to Optionee any taxes required to be withheld by Federal, state or local law as a result of the grant or exercise of this option. If the amount of any consideration payable to Optionee is insufficient to pay such taxes or if no consideration is payable to Optionee, upon request of the Company, Optionee shall pay to the Company in cash an amount sufficient for 

3/5

the Company to satisfy any Federal, state or local tax withholding requirements it may incur as a result of the grant or exercise of this option.
12.    Severability. Any word, phrase, clause, sentence or other provision herein which violates or is prohibited by any applicable law, court decree or public policy shall be modified as necessary to avoid the violation or prohibition and so as to make this Agreement enforceable as fully as possible under applicable law, and if such cannot be so modified, the same shall be ineffective to the extent of such violation or prohibition without invalidating or affecting the remaining provisions herein.
13.    Non-Waiver of Rights. The Company’s failure to enforce at any time any of the provisions of this agreement or to require at any time performance by Optionee of any of the provisions hereof shall in no way be construed to be a waiver of such provisions or to affect either the validity of this agreement, or any part hereof, or the right of the Company thereafter to enforce each and every provision in accordance with the terms of this agreement.
14.    Entire Agreement; Amendments. No modification, amendment or waiver of any of the provisions of this agreement shall be effective unless in writing specifically referring hereto and signed by the parties hereto. This agreement supersedes all prior agreements and understandings between Optionee and the Company to the extent that any such agreements or understandings conflict with the terms of this agreement.    
15.    Assignment. This agreement shall be freely assignable by the Company to and shall inure to the benefit of, and be binding upon, the Company, its successors and assigns and/or any other entity which shall succeed to the business presently being conducted by the Company.
16.    Governing Law. To the extent that Federal laws do not otherwise control, all determinations made, or actions taken pursuant hereto shall be governed by the laws of the state of New York, without regard to the conflict of laws rules thereof.
[signature page follows]

4/5

IN WITNESS WHEREOF, the Company has caused this Agreement to be executed on its behalf by the undersigned officer pursuant to due authorization, and Optionee has signed this Agreement to evidence his acceptance of the option herein granted and of the terms hereof, all as of the date hereof.

COMPANY:
TRAVELZOO 
By: ________________________________
Name: _____________________________
Title: ______________________________
Date: ______________________________

OPTIONEE:
By: ________________________________
Name: Scott Wang
Title: Head of Strategy, Asia Pacific 
Date: _______________________________

5/5Exhibit 10.1

 

	 	 

                                                        

                                                        

                                                       435
                                         Devon Park Drive, Suite 715

        Wayne,
        PA 19087

         

        t:
        610 254 4201 f: 610 717 3390

        aevigenomics.com

 

 

  

 

May 21, 2019

 

Michael McInaw

3416 W. Queen Lane

Philadelphia, PA 19129

 

Dear Mike,

 

On behalf of Aevi Genomic Medicine, Inc.
(“Aevi” or the “Company”), I am pleased to offer you the promotion to the position of Chief Financial Officer
on an interim basis, reporting to me as CEO of Aevi. The effective date of your promotion is June 1, 2019.

 

The terms of your employment are as follows:

 

Annual Base Salary: $180,000 (paid in accordance
with Aevi’s payroll policies), subject to withholding of taxes and other authorized deductions. The base salary will be reviewed
annually and subject to adjustment based on a recommendation from me, as the CEO of Aevi and at the discretion of the Compensation
Committee of our Board of Directors.

 

Retention Bonus: You are eligible to earn
two separate cash lump sum bonuses of $25,000 each. The first $25,000 bonus will become payable if you remain in active service
with Aevi through the filing date of its Form 10-Q for the fiscal quarter ended June 30, 2019 (the “First Bonus”).
The second $25,000 bonus will become payable if you remain in active service with Aevi through the filing date of its Form 10-Q
for the fiscal quarter ended September 30, 2019 (the “Second Bonus”). In the event that you are terminated by the Company
without Cause (as defined below) prior to the filing date of its Form 10-Q for the fiscal quarter ended June 30, 2019, Aevi will
pay you the First Bonus and Second Bonus. In the event that you are terminated by the Company without Cause after the First Bonus
is earned and before the filing date of its Form 10-Q for the fiscal quarter ended September 30, 2019, Aevi will pay you the Second
Bonus. If a Change in Control (as defined in the Aevi Genomic Medicine, Inc. Stock Incentive Plan) occurs and you remain in active
service with Aevi through such event, any unpaid First Bonus and/or Second Bonus will become earned and payable.

 

If your employment terminates for any reason
other than a termination by the Company without Cause prior to the date that the First Bonus and/or Second Bonus is earned or prior
to a Change in Control, you will not be eligible to receive the applicable retention bonus(es). If you earn the retention bonus(es),
payment will be made on the first normal payroll date after the applicable retention bonus is earned.

 

     

     

    

 

For purposes hereof, “Cause”
means any of the following (in each case as determined by the Company’s Board of Directors: (i) your conviction of, or plea
of nolo contendere to, a crime of embezzlement or fraud or any felony under the laws of the United States or any state thereof;
(ii) an act of fraud, gross negligence, willful misconduct or dishonesty by you that could reasonably be expected to be materially
injurious to the Company or an affiliate; (iii) your material breach of any of any agreement between you and the Company; (iv)
an act of moral turpitude committed by you that could reasonably be expected to lead to a material harm (financial or reputational)
to the Company or an affiliate; or (v) your alcoholism or illegal drug use or drug abuse.

 

Annual Bonus: Subject to the terms of the
company’s Annual Incentive Bonus program, provided that you continue in service through the date bonuses, if any, are paid,
you will be eligible to receive an annual bonus. The amount of the award is subject to the evaluation of performance at both the
Company and individual levels, as well as any other performance criteria that apply to your position.

 

Benefits: You and your dependents will
remain eligible for the Company-provided health insurance plan as well as dental, vision, life insurance and paid-time-off to the
same extent currently provided.

 

Employment at Will: Employment with Aevi
is at will meaning that your employment is not for any specific duration and may be terminated by either party at any time, with
or without cause.

 

Please confirm your acceptance of these
employment terms by signing this letter and returning a copy to me.

 

 

Kind regards,

  

 

Michael Cola

Chief Executive Officer

  

 

I accept the employment terms as set forth
above.

  

 

	By:	 /s/ Michael McInaw	 
	 	Name: Michael McInaw

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00296-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00296-of-00352.parquet"}]]